Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab

NCT00307931 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated early because of slow recruitment

Conditions

Interventions

Sponsor

UCB Pharma